Literature DB >> 1384061

Oncogenic ras triggers the activation of 42-kDa mitogen-activated protein kinase in extracts of quiescent Xenopus oocytes.

E K Shibuya1, A J Polverino, E Chang, M Wigler, J V Ruderman.   

Abstract

Quiescent, full-grown Xenopus oocytes, which are arrested at the G2/M border of meiosis, contain an inactive 42-kDa mitogen-activated protein kinase (p42MAPK) that is activated when oocytes are stimulated to resume the meiotic cell cycle. We have made extracts from these oocytes that respond to four cell cycle activators: oncogenic [Val12]Ras protein, clam cyclins A delta 60 and B delta 97, and the phosphatase inhibitor okadaic acid. All four induce the tyrosine phosphorylation and activation of p42MAPK. Both cyclins and okadaic acid, but not [Val12]Ras, also lead to activation of the endogenous cyclin B/cdc2 kinase complexes in extracts of quiescent oocytes. Using extracts prepared from cycloheximide-arrested interphase cells, we show that although p42MAPK activation can occur in response to cyclin-activated cdc2, the Ras-induced activation of p42MAPK occurs without intervening cdc2 activation. Neither the nononcogenic [Gly12]Ras nor [Val12,Arg186]Ras, a mutant that lacks the C-terminal consensus sequence directing prenylation and subsequent membrane association, is an effective activator of p42MAPK in vitro.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1384061      PMCID: PMC50227          DOI: 10.1073/pnas.89.20.9831

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  65 in total

Review 1.  Oncogenes, growth factors, and signal transduction.

Authors:  B J Druker; H J Mamon; T M Roberts
Journal:  N Engl J Med       Date:  1989-11-16       Impact factor: 91.245

2.  A sensitive method for detection of calmodulin-dependent protein kinase II activity in sodium dodecyl sulfate-polyacrylamide gel.

Authors:  I Kameshita; H Fujisawa
Journal:  Anal Biochem       Date:  1989-11-15       Impact factor: 3.365

3.  Oogenesis in Xenopus laevis (Daudin). I. Stages of oocyte development in laboratory maintained animals.

Authors:  J N Dumont
Journal:  J Morphol       Date:  1972-02       Impact factor: 1.804

4.  Relative roles of the pituitary, follicle cells, and progesterone in the induction of oocyte maturation in Rana pipiens.

Authors:  Y Masui
Journal:  J Exp Zool       Date:  1967-12

Review 5.  ras genes.

Authors:  M Barbacid
Journal:  Annu Rev Biochem       Date:  1987       Impact factor: 23.643

6.  Requirement for ras proto-oncogene function during serum-stimulated growth of NIH 3T3 cells.

Authors:  L S Mulcahy; M R Smith; D W Stacey
Journal:  Nature       Date:  1985 Jan 17-23       Impact factor: 49.962

7.  The p21 ras C-terminus is required for transformation and membrane association.

Authors:  B M Willumsen; A Christensen; N L Hubbert; A G Papageorge; D R Lowy
Journal:  Nature       Date:  1984 Aug 16-22       Impact factor: 49.962

8.  SCH9, a gene of Saccharomyces cerevisiae that encodes a protein distinct from, but functionally and structurally related to, cAMP-dependent protein kinase catalytic subunits.

Authors:  T Toda; S Cameron; P Sass; M Wigler
Journal:  Genes Dev       Date:  1988-05       Impact factor: 11.361

9.  Molecular cloning and characterization of the mRNA for cyclin from sea urchin eggs.

Authors:  J Pines; T Hunt
Journal:  EMBO J       Date:  1987-10       Impact factor: 11.598

10.  Mutants of H-ras that interfere with RAS effector function in Saccharomyces cerevisiae.

Authors:  T Michaeli; J Field; R Ballester; K O'Neill; M Wigler
Journal:  EMBO J       Date:  1989-10       Impact factor: 11.598

View more
  45 in total

1.  Induction of Ig light chain gene rearrangement in heavy chain-deficient B cells by activated Ras.

Authors:  A C Shaw; W Swat; L Davidson; F W Alt
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-02       Impact factor: 11.205

Review 2.  MAP kinase pathways: the first twenty years.

Authors:  Joseph Avruch
Journal:  Biochim Biophys Acta       Date:  2006-11-15

3.  Peptides containing a consensus Ras binding sequence from Raf-1 and theGTPase activating protein NF1 inhibit Ras function.

Authors:  G J Clark; J K Drugan; R S Terrell; C Bradham; C J Der; R M Bell; S Campbell
Journal:  Proc Natl Acad Sci U S A       Date:  1996-02-20       Impact factor: 11.205

4.  Activated Ras signals differentiation and expansion of CD4+8+ thymocytes.

Authors:  W Swat; Y Shinkai; H L Cheng; L Davidson; F W Alt
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-14       Impact factor: 11.205

5.  Distinct roles of PP1 and PP2A-like phosphatases in control of microtubule dynamics during mitosis.

Authors:  R Tournebize; S S Andersen; F Verde; M Dorée; E Karsenti; A A Hyman
Journal:  EMBO J       Date:  1997-09-15       Impact factor: 11.598

6.  The polo-like kinase Plx1 is required for activation of the phosphatase Cdc25C and cyclin B-Cdc2 in Xenopus oocytes.

Authors:  Y W Qian; E Erikson; F E Taieb; J L Maller
Journal:  Mol Biol Cell       Date:  2001-06       Impact factor: 4.138

7.  Dominant negative Ras enhances lactogenic hormone-induced differentiation by blocking activation of the Raf-Mek-Erk signal transduction pathway.

Authors:  Maria Grazia Cerrito; Traci Galbaugh; Weihan Wang; Treasa Chopp; David Salomon; Mary Lou Cutler
Journal:  J Cell Physiol       Date:  2004-11       Impact factor: 6.384

8.  Ultrasensitivity in the mitogen-activated protein kinase cascade.

Authors:  C Y Huang; J E Ferrell
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-17       Impact factor: 11.205

9.  Identification of the mitogen-activated protein kinase phosphorylation sites on human Sos1 that regulate interaction with Grb2.

Authors:  S Corbalan-Garcia; S S Yang; K R Degenhardt; D Bar-Sagi
Journal:  Mol Cell Biol       Date:  1996-10       Impact factor: 4.272

10.  Dependence of Mos-induced Cdc2 activation on MAP kinase function in a cell-free system.

Authors:  C Y Huang; J E Ferrell
Journal:  EMBO J       Date:  1996-05-01       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.